Precision medicine in action: #TAILORx #ASC018 #genomics via @NEJM https://t.co/yY58LdZY8g https://t.co/c8BQjgJRj4
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co/CffaoAPnmC
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @jesusanampa: momento histórico en el manejo de #cancer #MAMA Este estudio salvará a muchas mujeres de recibir quimioterapia en el futur…
#TAILORx: And here are the highly anticipated results in today’s @NEJM https://t.co/yY58LdZY8g #ASC018
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @GenomicHealth: .@NEJM publication on the long-awaited results of the #TAILORx study of #Oncotype DX, the largest ever breast cancer tre…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
Great news for estrogen receptor positive breast cancer patients who have tumors with an intermediate-risk Oncotype score! We have previously reported data that show that low-risk Oncotype tumors do not need... https://t.co/NuhsmrgDnE
New study shows early 85% of breast cancer patients can be spared chemotherapy. https://t.co/7fclNIlYbG
RT @elmodir: Adjuvant #Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer : https://t.co/sMf6mcRtsS
RT @elmodir: Adjuvant #Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer : https://t.co/sMf6mcRtsS
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @drrichardp: Important research on tests to make sure patients with breast cancer will actually benefit from chemotherapy ... it seems m…
RT @elmodir: Adjuvant #Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer : https://t.co/sMf6mcRtsS
Such an important plenary session! #ASC018 More research in other cancers is needed like this. Find a bio marker which allows us to avoid unnecessary treatment! Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @drrichardp: Important research on tests to make sure patients with breast cancer will actually benefit from chemotherapy ... it seems m…
RT @RamalingamMD: Another feather on the hat for @eaonc. #ASC018 @WinshipAtEmory https://t.co/aLqIGFx1yW
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @elmodir: Adjuvant #Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer : https://t.co/sMf6mcRtsS
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
Less and less chemotherapy https://t.co/VBuzozuUB0
Adjuvant #Chemotherapy Guided by a 21-Gene Expression Assay in #BreastCancer : https://t.co/sMf6mcRtsS
RT @skathire: Using a gene-expression signature test to avoid unnecessary adjuvant chemo in BrCa! Pretty striking results, 10K women rando…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @GenomicHealth: .@NEJM publication on the long-awaited results of the #TAILORx study of #Oncotype DX, the largest ever breast cancer tre…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @drrichardp: Important research on tests to make sure patients with breast cancer will actually benefit from chemotherapy ... it seems m…
RT @GenomicHealth: .@NEJM publication on the long-awaited results of the #TAILORx study of #Oncotype DX, the largest ever breast cancer tre…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @marklewismd: On the @nejm website they don’t mince words. The title link to this article is “UNNECESSARY ADJUVANT CHEMOTHERAPY IN BREAS…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
Important research on tests to make sure patients with breast cancer will actually benefit from chemotherapy ... it seems many will not https://t.co/aHhMif5bE1
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @MurtuzaRampurwa: Practice change coming to clinic tomorrow morning !! Although, for younger women, not enough to segregate by interme…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @marklewismd: On the @nejm website they don’t mince words. The title link to this article is “UNNECESSARY ADJUVANT CHEMOTHERAPY IN BREAS…
RT @ksase: RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/2…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @marklewismd: On the @nejm website they don’t mince words. The title link to this article is “UNNECESSARY ADJUVANT CHEMOTHERAPY IN BREAS…
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co/odiwl86To4
RT @roentgen66: Los resultados del estudio TAILORx presentados en #ASCO18 permitirán evitar quimioterapia en grupo de riesgo intermedio htt…
RT Transplant_Doc "RT NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/tCT76JxZ8P #ASCO18 https://t.co/Jxiwi6vlBf"
RT Transplant_Doc "Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co/TdiJk7d8xx"
Simultaneous publication & presentation #asco18 important #less is more paper - reduced need for chemo for many breast cancer patients https://t.co/uhGNycn2hU
Los resultados del estudio TAILORx presentados en #ASCO18 permitirán evitar quimioterapia en grupo de riesgo intermedio https://t.co/7ZIp4SWvl8
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/2Pyow1UkgR #ASCO18 https://t.co/Iu4CmGldWN
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co/6RJXzbGY4x
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
momento histórico en el manejo de #cancer #MAMA Este estudio salvará a muchas mujeres de recibir quimioterapia en el futuro. #ASCO18 #TAILORx @jsparano @MontefioreNYC @EinsteinMed https://t.co/avLZjt61XF
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @g_develasco: Real time @nejm @ASCO #ASCO18 and less chemo for #BreastCancer patients https://t.co/vlmFSjm7HX
RT @RamalingamMD: Another feather on the hat for @eaonc. #ASC018 @WinshipAtEmory https://t.co/aLqIGFx1yW
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co/R4sp4zSH6p
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
And here it is! Excellent! https://t.co/1QcyJYAUpg
RT @AJacomeMD: TAILORx was just published. Let’s pay attention to inclusion criteria: node+ patients and tumor > 5cm were not included. #Pr…
RT @marklewismd: On the @nejm website they don’t mince words. The title link to this article is “UNNECESSARY ADJUVANT CHEMOTHERAPY IN BREAS…
RT @marklewismd: On the @nejm website they don’t mince words. The title link to this article is “UNNECESSARY ADJUVANT CHEMOTHERAPY IN BREAS…
TAILORx was just published. Let’s pay attention to inclusion criteria: node+ patients and tumor > 5cm were not included. #PrecisionMedicine does not mean giving less chemo. It’s the right drug for the right patient based on molecular alterations. #ASCO1
RT @marklewismd: On the @nejm website they don’t mince words. The title link to this article is “UNNECESSARY ADJUVANT CHEMOTHERAPY IN BREAS…
On the @nejm website they don’t mince words. The title link to this article is “UNNECESSARY ADJUVANT CHEMOTHERAPY IN BREAST CANCER”. 😳 Practice-changing indeed #ASCO18 #bcsm https://t.co/fhRuNirSTH
RT @Monthy_A: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co/6WKAoHoNWC
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co/6WKAoHoNWC
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @notahedge: #ASCO2018 #bcsm Rx for premenopausal women RS 18- 25 remains a grey zone. https://t.co/RubHiCOHgp
RT @skathire: Using a gene-expression signature test to avoid unnecessary adjuvant chemo in BrCa! Pretty striking results, 10K women rando…
RT @GenomicHealth: .@NEJM publication on the long-awaited results of the #TAILORx study of #Oncotype DX, the largest ever breast cancer tre…
RT @MurtuzaRampurwa: Practice change coming to clinic tomorrow morning !! Although, for younger women, not enough to segregate by interme…
Here is the original article about the breast cancer study making headlines today. Looking forward to digging in. https://t.co/ZsiCE73cfD
Using a gene-expression signature test to avoid unnecessary adjuvant chemo in BrCa! Pretty striking results, 10K women randomized to Rx guided gene-expression test result Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM
RT @GenomicHealth: .@NEJM publication on the long-awaited results of the #TAILORx study of #Oncotype DX, the largest ever breast cancer tre…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
From plenary to publication, at the same time. https://t.co/6wxJ06tvrG
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…
RT @notahedge: #ASCO2018 #bcsm Rx for premenopausal women RS 18- 25 remains a grey zone. https://t.co/RubHiCOHgp
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #…